PYRIDIN-2(1H)-ONE QUINOLINONE DERIVATIVES AS MUTANT-ISOCITRATE DEHYDROGENASE INHIBITORS

The invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of cell-proliferation disorders and cancers, having the Formula: (I) where A, U, W1, W2, W3, R1-R6, and R9 are described herein.

Saved in:
Bibliographic Details
Main Authors LIN, Jian, CARAVELLA, Justin Andrew, DIEBOLD, R. Bruce, ERICSSON, Anna, LU, Wei, WANG, Zhongguo, GUSTAFSON, Gary, ASHWELL, Susan, LANCIA, David R. Jr, CAMPBELL, Ann-Marie
Format Patent
LanguageEnglish
French
German
Published 10.01.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of cell-proliferation disorders and cancers, having the Formula: (I) where A, U, W1, W2, W3, R1-R6, and R9 are described herein.
AbstractList The invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of cell-proliferation disorders and cancers, having the Formula: (I) where A, U, W1, W2, W3, R1-R6, and R9 are described herein.
Author ASHWELL, Susan
CARAVELLA, Justin Andrew
GUSTAFSON, Gary
ERICSSON, Anna
WANG, Zhongguo
LIN, Jian
LANCIA, David R. Jr
CAMPBELL, Ann-Marie
DIEBOLD, R. Bruce
LU, Wei
Author_xml – fullname: LIN, Jian
– fullname: CARAVELLA, Justin Andrew
– fullname: DIEBOLD, R. Bruce
– fullname: ERICSSON, Anna
– fullname: LU, Wei
– fullname: WANG, Zhongguo
– fullname: GUSTAFSON, Gary
– fullname: ASHWELL, Susan
– fullname: LANCIA, David R. Jr
– fullname: CAMPBELL, Ann-Marie
BookMark eNqNirsOgjAUQDvo4OsfOurQoVTjXOFqb6IttBcMEyGmTgZI8P8jJn6Aw8k5w1myWdd3ccHuee0xQyuSrTQ74SzwokTrrhNTZ-Cx0oQVBK4Dv5WkLQkMLkXymr6DqTPvLmB1AI7W4AnJ-bBm82f7GuPm5xXjZ6DUiDj0TRyH9hG7-G4g3yeHo1RSK_XH8gGrzjKS
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate DÉRIVÉS DE PYRIDIN-2-(1H)-ONE-QUINOLINONE EN TANT QU'INHIBITEURS D'ISOCITRATE DÉSHYDROGÉNASE
PYRIDIN-2(1H)-ON-CHINOLIN-DERIVATE ALS INHIBITOREN DER MUTANTEN ISOCITRATDEHYDROGENASE
ExternalDocumentID EP4257131A3
GroupedDBID EVB
ID FETCH-epo_espacenet_EP4257131A33
IEDL.DBID EVB
IngestDate Fri Oct 18 06:06:28 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP4257131A33
Notes Application Number: EP20230176702
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240110&DB=EPODOC&CC=EP&NR=4257131A3
ParticipantIDs epo_espacenet_EP4257131A3
PublicationCentury 2000
PublicationDate 20240110
PublicationDateYYYYMMDD 2024-01-10
PublicationDate_xml – month: 01
  year: 2024
  text: 20240110
  day: 10
PublicationDecade 2020
PublicationYear 2024
RelatedCompanies Forma Therapeutics, Inc
RelatedCompanies_xml – name: Forma Therapeutics, Inc
Score 3.5124283
Snippet The invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of cell-proliferation...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title PYRIDIN-2(1H)-ONE QUINOLINONE DERIVATIVES AS MUTANT-ISOCITRATE DEHYDROGENASE INHIBITORS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240110&DB=EPODOC&locale=&CC=EP&NR=4257131A3
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEG8QjfqmqBG_sgez6MMiY2UbD8SMrbga6eZWEJ4ILTXhZRCZ8d_3tgD6og9NLm1zaS-9Xn_XuxahWwcgg4sVNhoK2wBQnKnRVkIa2BLWu3RcoUQZIMvscICfR61RBc03uTDlO6Ff5eOIoFES9D0v9-vljxMrKGMrVw9iDlWLxx7vBPoaHYN5AnOmB90OiaMg8nXfB0pnSadYmqZletYO2oVTtFMoAxl2i6SU5W-L0jtCezEwy_JjVFFZDR34m4_Xami_v77vBnKteqsT9BaPExpQZjTvzPDeiBjRXgeURS9QgA4AkA09Tock1bxU6w-4x7hB08inPPF40SEcB0n0RJiXEo2ykHYpj5L0FGk9wv3QgBFOttKYkHg7F-sMVbNFps6R5jpNCehiZkuzjafSFdOWLVqOwtK2sCNndVT_k83FP22X6LAQa-F0MBtXqJp_fKprMMO5uCkF-A2o9oUt
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFG8QjXhT1IifO5hFD4uMlW0ciBlbcVXo5lYQToSOmnAZRGb8931bAL3ooclL27z0vfTX118_Ebq1gDLYWGKtLrEJBMWaai0pEg0bwnhPLFtIURyQZaY_wM-j5qiE5pu7MMU7oV_F44iAqATwnhXj9fJnEcsrzlauHsQcshaPXd721DU7hvAE4Uz1Om0SBl7gqq4Lksqidt41dUN3jB20CzNsKwcDGXbySynL3xGle4j2QlCWZkeoJNMqqribj9eqaL-_3u8GcQ291TF6C8cR9SjTGne6f68FjCivA8qCHiSQPSBkQ4fTIYkVJ1b6A-4wrtE4cCmPHJ5X8MdeFDwR5sREocynHcqDKD5BSpdw19eghZOtNyYk3NpinKJyukjlGVJsq5EAu5iZid7C08QW06YpmpbEiWlgK5nVUO1PNef_lN2gis_7vQkY83KBDnIX5wsQev0SlbOPT3kFITkT14UzvwEUmogg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PYRIDIN-2%281H%29-ONE+QUINOLINONE+DERIVATIVES+AS+MUTANT-ISOCITRATE+DEHYDROGENASE+INHIBITORS&rft.inventor=LIN%2C+Jian&rft.inventor=CARAVELLA%2C+Justin+Andrew&rft.inventor=DIEBOLD%2C+R.+Bruce&rft.inventor=ERICSSON%2C+Anna&rft.inventor=LU%2C+Wei&rft.inventor=WANG%2C+Zhongguo&rft.inventor=GUSTAFSON%2C+Gary&rft.inventor=ASHWELL%2C+Susan&rft.inventor=LANCIA%2C+David+R.+Jr&rft.inventor=CAMPBELL%2C+Ann-Marie&rft.date=2024-01-10&rft.externalDBID=A3&rft.externalDocID=EP4257131A3